Superworth

Glucotrack price to book ratio GCTK

Market value divided by the book value of the company's net assets, since 2020.

Today, Nov 2, 2026
n/m
not a meaningful number
Last meaningful
0.3×
May 2026
6-year median
68.1×
6-year range
0.2× to 198×
Peer median
0.2×

Glucotrack's price to book ratio is not a meaningful number today: shareholders' equity was zero, negative or not reported, so price to book does not exist.

It was last meaningful in May 2026, at 0.3×.

On the days it had one over the last 6 years, its median was 68.1×, from 0.2× in Mar 2026 to 198× in Jul 2024.

Price to book ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far0.3×0.2×0.7×
20250.7×0.2×1.1×
2024147×7.8×198×
20239.8×4.4×150×
202292.7×75.3×122×
202199.1×44.7×148×
202071.2×47.3×82.3×

Against its peers

Companies in Medical - Instruments & Supplies nearest Glucotrack's size, closest first, today.

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Glucotrack

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.